Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141541PMC
http://dx.doi.org/10.3389/fimmu.2024.1403802DOI Listing

Publication Analysis

Top Keywords

commentary efficacy
4
efficacy safety
4
safety innovative
4
innovative monoclonal
4
monoclonal antibodies
4
antibodies adults
4
adults generalized
4
generalized myasthenia
4
myasthenia gravis
4
gravis bayesian
4

Similar Publications

Elegant and Innovative Recoding Strategies for Advancing Vaccine Development.

Vaccines (Basel)

January 2025

Department of Veterinary Microbiology and Immunology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E2, Canada.

Recoding strategies have emerged as a promising approach for developing safer and more effective vaccines by altering the genetic structure of microorganisms, such as viruses, without changing their proteins. This method enhances vaccine safety and efficacy while minimizing the risk of reversion to virulence. Recoding enhances the frequency of CpG dinucleotides, which in turn activates immune responses and ensures a strong attenuation of the pathogens.

View Article and Find Full Text PDF

Cell-Based Therapy for Cerebral Palsy: A Puzzle in Progress.

Cell J

January 2025

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Email:

Cell-based therapy has shown promising outcomes in the treatment of cerebral palsy (CP). However, there is no consensus on a standard therapeutic protocol regarding the source of cells, optimal cell dose, timing and frequency of cell injections, route of administration, or the use of combination therapy. This lack of consensus necessitates a comprehensive investigation to clarify these crucial yet undefined factors in cell-based therapy for CP patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!